The Discounted Cash Flow (DCF) valuation of Bristol-Myers Squibb Co (BMY) is 60.87 USD. With the latest stock price at 50.45 USD, the upside of Bristol-Myers Squibb Co based on DCF is 20.7%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 6.6% | 5.9% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 46.39 - 84.05 | 60.87 |
| Upside | -8.0% - 66.6% | 20.7% |